Blood Transfusion for A-Negative Patient with O-Positive Liver Donor
For an A-negative patient undergoing liver transplantation from an O-positive donor, transfuse O-negative red blood cells initially, then transition to A-negative red blood cells once available, while monitoring closely for passenger lymphocyte syndrome (PLS) and hemolysis starting around day 6 post-transplant.
Rationale for Blood Type Selection
Immediate Perioperative Period
In emergency or massive hemorrhage situations during liver transplantation, group O RhD negative red blood cells are the blood group of choice when immediate transfusion is needed 1. For women of childbearing potential (which includes your A-negative patient if <50 years old), O RhD negative blood should be prioritized to prevent RhD alloimmunization 2.
However, the guidelines acknowledge that O RhD positive blood is acceptable for males and postmenopausal females when O negative supplies are limited 3, 1. Given the scarcity of O-negative blood as a resource 3, once the patient's blood type is confirmed (approximately 10 minutes), group-specific blood (A-negative in this case) should be used at the earliest possible opportunity 1.
Post-Transplant Period: The Critical Complication
The major concern in this ABO-unmatched transplant scenario (O donor → A recipient) is passenger lymphocyte syndrome (PLS), which causes hemolytic anemia. This occurs when donor lymphocytes in the transplanted liver produce antibodies against the recipient's red blood cells.
Key clinical features of PLS:
- Hemolysis typically begins 6-12 days post-transplant (mean 9.2 days) 4, 5
- Hemoglobin can drop dramatically (mean decrease 4.8 g/dL) 4
- Most problematic in O donor → A recipient transplants, with 56% developing donor-derived antibodies and hemolysis 4
- Anti-A antibodies appear in patient serum and on red blood cell membranes 6, 5
Specific Transfusion Protocol
During Surgery and Immediate Post-Op
- Use O-negative red blood cells if patient is female of childbearing age
- Transition to A-negative red blood cells once blood bank confirms type (within 15-20 minutes) 2
- Use plasma-poor red cells in optimal additive solution (leucodepleted) 3
Days 6-30 Post-Transplant (PLS Risk Period)
Monitor closely:
- Daily hemoglobin and bilirubin levels starting day 6 5
- Direct antiglobulin test (DAT) 5
- Unexpected antibody screening 5
If hemolysis develops:
- Transfuse O-negative washed red blood cells (not A-negative) 6, 4, 5
- The "washed" component removes plasma antibodies
- Continue O-negative transfusions until donor-derived antibodies clear (mean duration 15.2 days) 4
- Consider corticosteroids (e.g., prednisolone 60 mg for 3 days) 6
- Patients typically require 7-8 units during hemolytic period 4
After PLS Resolution
- Resume A-negative red blood cells once DAT becomes negative and anti-A antibodies are no longer detectable
Critical Pitfalls to Avoid
Do NOT transfuse A-negative blood during active PLS - the donor-derived anti-A antibodies will destroy the patient's own A-positive red cells 6, 4, 5
Do NOT assume hemolysis won't occur - 56% of O→A liver transplants develop clinically significant hemolysis 4
Do NOT wait for symptoms - begin monitoring hemoglobin and DAT on day 6 proactively 5
Do NOT overlook the Rh status - while the donor is O-positive, this primarily affects platelet transfusions; for red cells, maintain A-negative or O-negative to prevent RhD alloimmunization if patient is female and childbearing age 1, 7
Platelet and Plasma Considerations
- Platelets: Can use O-positive platelets, though they contain small amounts of RBCs (0.00043-0.036 mL) 7
- Fresh frozen plasma: Use AB plasma (universal donor for plasma) or A plasma to avoid anti-A antibodies in O plasma that could cause hemolysis 7
This approach balances the immediate surgical needs with the predictable complication of PLS in ABO-mismatched liver transplantation, prioritizing patient safety while conserving scarce O-negative blood resources 3, 1.